ECB Signals Possible Interest Rate Move if Inflation Outlook Fails to Improve 
Morgan Stanley Bets on Optical Component Stocks in Greater China Tech Sector 
South Korea Central Bank Signals Inflation Concerns as Oil Prices Surge 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
Asian Stocks Rise Despite Middle East Tensions as Chipmakers Boost Markets 
Trump to Visit China for Key U.S.-China Summit With Xi Jinping 
UOB Q1 Profit Meets Expectations as Loan Growth Offsets Lower Interest Rates 
Japan’s Yen Intervention and BOJ Rate Hike Bets Support Currency Recovery 
Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone 
AcadeMedia Q3 Profit Climbs as International and Adult Education Segments Drive Growth 
US Stock Futures Slip as Trump Rejects Iran Peace Proposal Amid Rising Middle East Tensions 
Trump Rejects Iran Proposal as Strait of Hormuz Crisis Pushes Oil Prices Higher 
Dollar Rises as Strait of Hormuz Crisis Pushes Oil Prices Higher 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Asian Currencies Slide as Iran Tensions Boost Dollar and Oil Prices 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
CSL Shares Crash as Profit Warning and $5 Billion Impairment Shake Investors 
Roche will be making big changes in the organization of its employees, which is estimated to be around 100,000 in number. The company is taking this step as it implements new prioritization of the works.
Announcement of change in the workforce
As part of the plans, Roche will be eliminating 300 to 400 jobs this year. The affected employees will be the ones working at the company’s product development sites.
According to Reuters, the news about job cuts was announced by Levi Garraway, the firm’s chief medical officer. Through a video call with the employees, he directly told them what the company is planning to do.
"We have made the difficult decision to reduce our workforce in PD by around five to seven percent by the end of the year," he said. "And that equates to somewhere between 300 to 400 roles that will be impacted globally."
The company knows that this is a big blow to the affected workers, so Roche will try to lessen the impact by working with employees. It was not mentioned, though, how the company intends to help those who are about to lose their position.
Who are set to lose their jobs
Based on the information shared, the Roche employees that will be cut from the company are those who are in the product development units and working in the area of project management, business management, administrative support, project delivery, managers, and posts in learning and development.
The product development sites that will cut workers are located in Canada, Britain, United States, Switzerland, and China. Those who will be laid off are set to be notified between the months of August and October, and British employees are the first ones to go.
Felix Arellano, Roche’s head of global drug safety, admitted that this is the hardest thing that he had to do since he started working for the company. He was referring to the fact that he has to send off colleagues as they have been eliminated by the company, as per Fierce Biotech.
Finally, while Roche is cutting jobs, some of the other major pharmaceutical companies are looking for more workers. Most are building new factories, so they need to hire hundreds of workers.
